Home > Healthcare > Medical Devices > Therapeutic Devices > Ileostomy Market

Ileostomy Market Analysis

  • Report ID: GMI12721
  • Published Date: Dec 2024
  • Report Format: PDF

Ileostomy Market Analysis

Based on type, the market is segmented as end ileostomy and loop ileostomy. The end ileostomy segment is expected to drive business growth and expand at a CAGR of 5.2%, reaching over USD 1.5 billion by 2034.
 

  • Laparoscopic and robotic-assisted surgeries have made end ileostomy procedures less invasive, reducing recovery times and increasing acceptance among patients. Easier recovery has encouraged more patients and healthcare providers to opt for end ileostomies, particularly in cases requiring permanent solutions.
     
  • End ileostomies are often chosen for their durability and lower complication rates compared to temporary loop ileostomies. This preference is particularly strong among patients with severe conditions or after failed restorative procedures. In addition, innovations in stoma care products, such as odor-resistant bags, skin-friendly adhesives, and discreet designs, have made living with an end ileostomy more manageable.
     

Based on product, the market is segmented as ostomy bags and accessories. The ostomy bags segment held majority revenue share and is expected to reach around USD 1.7 billion by 2034.
 

  • The demand for ostomy bags has been steadily increasing due to their critical role in managing waste elimination for individuals with ileostomies, colostomies, or urostomies. These bags are essential for patients post-surgery and are pivotal in improving quality of life.
     
  • In addition, the increasing incidence of conditions such as colorectal cancer, Crohn’s disease, ulcerative colitis, and diverticulitis drives the demand for ostomy surgeries, directly impacting the need for ostomy bags.
     
  • Furthermore, ostomy bags are indispensable post-surgery for waste collection. The growing number of ileostomy and colostomy procedures has increased their usage. Both short-term (loop ostomies) and long-term (end ostomies) patients rely on these products.
     

Based on application, the market is segmented as colorectal cancer, ulcerative colitis, crohn's disease, and other applications. The colorectal cancer segment is expected to drive business growth and expand at a CAGR of 5.4%, reaching over USD 766.8 million by 2034.
 

  • Increased adoption of colorectal cancer screening programs in developed and emerging markets has led to early-stage diagnoses, driving surgical intervention rates and subsequent ostomy requirements. The risk of colorectal cancer increases significantly with age, with most diagnoses occurring in individuals aged 50 and above. As per the statistics by WCRF International, there were over 160 thousand new cases of colorectal cancer in the U.S. in 2022.
     
  • Moreover, the availability of patient support groups and resources for colorectal cancer survivors is promoting acceptance of ostomy products. Programs emphasizing post-cancer rehabilitation include ileostomy care as a critical component, boosting demand.
     
Ileostomy Market, By End Use (2024)

Baszd on end use, the market is classified into home care settings, hospitals and specialty clinics, and ambulatory surgical centers. The home care settings segment dominated the market with a revenue share of 50.1% in 2024.
 

  • The rise of telemedicine provides an avenue for patients to receive consultations from ostomy care specialists without leaving their homes. Virtual support groups also play a key role in patient confidence, promoting better care practices.
     
  • Further, home care is often a more affordable alternative to hospitalization or long-term care facilities, which is a key factor in driving the growth of this segment. Many patients prefer receiving care at home as it is more comfortable and familiar. The move to home healthcare has been increasingly popular in the last few years, particularly with chronic conditions such as colorectal cancer, Crohn’s disease, and ulcerative colitis.
     
U.S. Ileostomy Market, 2021 – 2034 (USD Million)

U.S. ileostomy market accounted for USD 228.4 million in 2024 and is anticipated to grow at a CAGR of 3.6% between 2025 to 2034 period.
 

  • The U.S. has one of the highest rates of colorectal cancer in the world. For instance, as per the data reported by The Centers for Disease Control and Prevention, around 52,967 people died from colorectal cancer in 2022. Many of these patients undergo colectomy surgeries, leading to an increased need for ileostomy and colostomy care products.
     
  • Many elderly individuals live with chronic conditions that necessitate long-term ostomy care, further contributing to the market growth. Moreover, conditions such as Crohn’s disease and ulcerative colitis are prevalent in the U.S., both of which often require ileostomy surgeries. The increasing rates of these diseases contribute to the growing demand for ostomy products.
     

U.K. ileostomy market is projected to grow remarkably in the coming years.
 

  • Ostomy bags and accessories are increasingly available in customized designs for active individuals, which is appealing to UK consumers seeking products that fit their lifestyle needs.
     
  • There is a growing emphasis on educating patients about ostomy care. Support from healthcare providers, online resources, and patient advocacy organizations have empowered more people to confidently manage their ostomies at home.
     
  • Furthermore, specialized rehabilitation programs for ostomy patients are helping individuals adjust to life post-surgery, which drives the need for sustained access to high-quality ostomy products.

China holds a dominant position in the Asia Pacific ileostomy market.
 

  • Domestic manufacturers are innovating to create cost-effective, high-quality products suited to local needs, such as reusable and eco-friendly options. In addition, domestic and international suppliers are increasingly offering home delivery of ostomy products, which is gaining popularity in urban areas.
     
  • Further, government-backed health insurance programs and private insurance policies are increasingly covering ostomy products, making them more accessible to a broader population.
     
  • China's ostomy products market is poised for rapid growth due to rising healthcare awareness, increasing prevalence of diseases requiring ostomies, and advancements in healthcare infrastructure. While challenges such as limited access in rural areas and cultural stigmas around ostomy surgeries remain, ongoing educational initiatives and government support are addressing these issues.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global ileostomy industry was valued at USD 1.2 billion in 2024 and is projected to grow at a 5% CAGR from 2025 to 2034, driven by the increasing prevalence of gastrointestinal diseases and a shift toward homecare settings.

The end ileostomy segment is expected to grow at a 5.2% CAGR, reaching over USD 1.5 billion by 2034, as advancements in laparoscopic and robotic-assisted surgeries make procedures less invasive and recovery times shorter.

The U.S. ileostomy market was valued at USD 228.4 million in 2024 and is anticipated to grow at a 3.6% CAGR from 2025 to 2034, supported by the high prevalence of colorectal cancer in the country.

Key players in the market include Alcare, B. Braun, Coloplast, ConvaTec Group, Cymed Micro Skin, Flexicare, Hollister, Marlen Manufacturing, Nu-Hope Labs, Perma-Type, Safe n Simple, Salts Healthcare, and Smith & Nephew.

Ileostomy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 15
  • Tables & Figures: 182
  • Countries covered: 19
  • Pages: 140
 Download Free Sample